All Pharma News
Ex-CinCor CEO Marc de Garidel lands at Abivax after negotiating $1.8B cash sale

Ex-CinCor CEO Marc de Garidel lands at Abivax after negotiating $1.8B cash sale
Amber Tong ENDPTS
06 Apr 2023
Share Share
AstraZeneca Acquires CinCor for $1.3B Upfront

AstraZeneca Acquires CinCor for $1.3B Upfront
CONTRACT PHARMA
03 Mar 2023
Share Share
CinCor Announces Receipt of Minutes with FDA on Planned PIII of Baxdrostat

CinCor Announces Receipt of Minutes with FDA on Planned PIII of Baxdrostat
GLOBENEWSWIRE
21 Feb 2023
Share Share
AstraZeneca eagerness for CinCor revealed in larger first offer

AstraZeneca eagerness for CinCor revealed in larger first offer
James Waldron FIERCE BIOTECH
24 Jan 2023
Share Share
How the price of AstraZeneca`s buyout of Cincor fell by $1.4B

How the price of AstraZeneca`s buyout of Cincor fell by $1.4B
Nicole DeFeudis ENDPTS
23 Jan 2023
Share Share
AstraZeneca Begins Tender Offer to Acquire CinCor Pharma, Inc.

AstraZeneca Begins Tender Offer to Acquire CinCor Pharma, Inc.
BUSINESSWIRE
23 Jan 2023
Share Share
AstraZeneca to acquire CinCor Pharma in nearly $2 billion deal

AstraZeneca to acquire CinCor Pharma in nearly $2 billion deal
PRESS RELEASE
10 Jan 2023
Share Share
CinCor Pharma to be Acquired by AstraZeneca

CinCor Pharma to be Acquired by AstraZeneca
GLOBENEWSWIRE
09 Jan 2023
Share Share
CinCor`s hypertension drug loses halo after phase 2 fail

CinCor`s hypertension drug loses halo after phase 2 fail
James Waldron FIERCEBIOTECH
29 Nov 2022
Share Share
CinCor Announces Topline Data for Phase 2 HALO Trial Evaluating Baxdrostat

CinCor Announces Topline Data for Phase 2 HALO Trial Evaluating Baxdrostat
GLOBENEWSWIRE
28 Nov 2022
Share Share